PREMPRO (PREMARIN;CYCRIN) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prempro (premarin;cycrin), and when can generic versions of Prempro (premarin;cycrin) launch?
Prempro (premarin;cycrin) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in PREMPRO (PREMARIN;CYCRIN) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREMPRO (PREMARIN;CYCRIN)?
- What are the global sales for PREMPRO (PREMARIN;CYCRIN)?
- What is Average Wholesale Price for PREMPRO (PREMARIN;CYCRIN)?
Summary for PREMPRO (PREMARIN;CYCRIN)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PREMPRO (PREMARIN;CYCRIN) at DailyMed |
-patent-expirations.png "PREMPRO (PREMARIN;CYCRIN) drug patent expirations")
US Patents and Regulatory Information for PREMPRO (PREMARIN;CYCRIN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PREMPRO (PREMARIN;CYCRIN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PREMPRO (PREMARIN;CYCRIN)
See the table below for patents covering PREMPRO (PREMARIN;CYCRIN) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 3726093 | ⤷ Sign Up | |
| Australia | 3140584 | ⤷ Sign Up | |
| Luxembourg | 91096 | ⤷ Sign Up | |
| Hungary | 9402457 | ⤷ Sign Up | |
| Luxembourg | 90697 | ⤷ Sign Up | |
| Denmark | 0628052 | ⤷ Sign Up | |
| Austria | 174342 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREMPRO (PREMARIN;CYCRIN)
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0136011 | SPC/GB00/025 | United Kingdom | ⤷ Sign Up | SPC/GB00/025: 20040802, EXPIRES: 20090801 |
| 0136011 | 99C0003 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306 |
| 0136011 | 91096 | Luxembourg | ⤷ Sign Up | 91096, EXPIRES: 20090802 |
| 0136011 | SPC/GB98/034 | United Kingdom | ⤷ Sign Up | SPC/GB98/034: 20040802, EXPIRES: 20090801 |
| 0136011 | SPC/GB00/028 | United Kingdom | ⤷ Sign Up | SPC/GB00/028: 20040802, EXPIRES: 20090801 |
| 0136011 | C00136011/03 | Switzerland | ⤷ Sign Up | PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417 |
| 0136011 | 97C0056 | Belgium | ⤷ Sign Up | PRODUCT NAME: OESTROGENES CONJUGUES + MEDROXYPROGESTERONACETAS; NAT. REGISTRATION NO/DATE: 428 IS 194 F 3 19970520; FIRST REGISTRATION: CH 52649 19940826 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
